Results 11 to 20 of about 1,266 (177)
Superiority of tiotropium plus olodaterol in comparison with salmeterol plus fluticasone
International Journal of COPD, 2016 Tomohiro Tamura, Hiroaki Satoh Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Ibaraki, Japan We read with interest the article entitled “The lung function profile of once-daily tiotropium and olodaterol via ...
Tamura T, Satoh H
doaj +6 more sources
Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity
International Journal of COPD, 2018 Masakazu Ichinose,1 Yoshiaki Minakata,2 Takashi Motegi,3 Jun Ueki,4 Yasuhiro Gon,5 Tetsuo Seki,6 Tatsuhiko Anzai,7 Shuhei Nakamura,6 Kazuto Hirata8 1Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 2Department of
Ichinose M +8 more
doaj +6 more sources
Efficacy of tiotropium-olodaterol fixed-dose combination in COPD [PDF]
International Journal of Chronic Obstructive Pulmonary Disease, 2016 Tiotropium-olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-acting muscarinic antagonist (LAMA) and a long-acting beta(2)-agonist (LABA), commercialized under the name of Spiolto or Stiolto ...
Brusselle, Guy, Joos, Guy, Derom, Eric
core +6 more sources
Olodaterol for the treatment of asthma
Expert Opinion on Investigational Drugs, 2016 INTRODUCTION: Long-acting β-agonist (LABA)/inhaled corticosteroid (ICS) combinations are still the mainstay of asthma therapy but there is a pressing need to increase adherence to the prescribed treatment achievable in general by reducing the dose ...
Cazzola M +3 more
core +3 more sources
Olodaterol for the treatment of chronic obstructive pulmonary disease
American Journal of Health-System Pharmacy, 2016 Purpose. Published data on the pharmacology, pharmacokinetics, efficacy, and safety of the once-daily, long-acting β2-agonist (LABA) olodaterol are reviewed. Summary. Olodaterol (Striverdi Respimat, Boehringer Ingelheim), a LABA with high selectivity for
Kabbara, Wissam K. +2 more
core +4 more sources
Respiratory maze: An anatomical variant of tracheal bronchus. [PDF]
Respirol Case RepTracheal bronchus is a rare congenital abnormality of bronchial variation arising from trachea. Special attention should be paid during intubation as it can potentially obstruct the bronchus. Key message This case highlights an uncommon anatomical variation in the airway known as Tracheal bronchus, which can sometimes lead to recurrent pneumonia. It is
Gullapalli D, Tangutoori S, Ganti SS.
europepmc +2 more sources
Systematic review comparing LABA, olodaterol, and indacaterol: limitations
International Journal of Chronic Obstructive Pulmonary Disease, 2014 James F Donohue Pulmonary Diseases and Critical Care Medicine, UNC School of Medicine, Chapel Hill, NC, USA Dear editor Roskell et al present a systematic review comparing the long-acting beta2 agonists (LABA), olodaterol, and indacaterol in ...
Donohue JF
core +6 more sources
International Journal of COPD, 2016 Gary T Ferguson,1 Jill P Karpel,2 Emmanuelle Clerisme-Beaty,3 Lars Grönke,4 Florian Voß,4 Roland Buhl5 1Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, 2North Shore Medical Arts LLP, Great Neck, NY, 3Boehringer ...
Ferguson GT +5 more
doaj +1 more source
Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
International Journal of COPD, 2016 Eric Derom, Guy G Brusselle, Guy F Joos Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumAbstract: Tiotropium–olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-
Derom E, Brusselle GG, Joos GF
doaj +1 more source
International Journal of COPD, 2015 Masakazu Ichinose,1 Ayako Takizawa,2 Toshiyasu Izumoto,2 Yusuke Tadayasu,2 Alan L Hamilton,3 Christina Kunz,4 Yoshinosuke Fukuchi51Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan; 2Nippon Boehringer ...
Ichinose M +6 more
doaj +1 more source